We found that GTA administration during the subacute phase of ischemic stroke increased the level of free lauric acid, an intermediate product for lipogenesis under FASN catalysis, indicating that GTA enhanced FASN-driven lipogenesis in the peri-infarct area after intragastric administration. Here, FASN is linked to ischemic stroke.